Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Accumulated Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Accumulated Expenses for 16 consecutive years, with $53.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 16.46% to $53.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $53.1 million through Dec 2025, up 16.46% year-over-year, with the annual reading at $53.1 million for FY2025, 16.46% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $53.1 million at AtriCure, up from $49.4 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $53.1 million in Q4 2025, with the low at $713000.0 in Q1 2021.
  • Average Accumulated Expenses over 5 years is $34.1 million, with a median of $32.5 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses crashed 90.41% in 2021, then soared 3451.33% in 2022.
  • Over 5 years, Accumulated Expenses stood at $36.1 million in 2021, then decreased by 8.51% to $33.0 million in 2022, then soared by 35.31% to $44.7 million in 2023, then rose by 2.03% to $45.6 million in 2024, then grew by 16.46% to $53.1 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $53.1 million, $49.4 million, and $40.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.